Related Articles
Matrix metalloproteinase‑2 and ‑9 and tissue inhibitor of metalloproteinase‑1 and ‑2 in sera and urine of patients with renal carcinoma
Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase‑9 (MMP‑9) and their complex MMP‑9/NGAL in sera and urine of patients with kidney tumors
Clinical significance of urinary vascular endothelial growth factor in patients with superficial bladder tumors
Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer
Profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases proteins in bladder urothelial carcinoma